blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3039421

EP3039421 - SERUM ANTIBODY ASSAY FOR DETERMINING PROTECTION FROM MALARIA, AND PRE-ERYTHROCYTIC SUBUNIT VACCINES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  02.03.2018
Database last updated on 16.09.2024
FormerRequest for examination was made
Status updated on  14.11.2017
Most recent event   Tooltip02.03.2018Application deemed to be withdrawnpublished on 04.04.2018  [2018/14]
Applicant(s)For all designated states
Sanaria Inc.
9800 Medical Center Drive - A209
Rockville, MD 20850 / US
For all designated states
Antigen Discovery Inc.
1 Technology Drive E309
Irvine, CA 92618 / US
For all designated states
The United States of America, represented by the Secretary, Department of Health and Human Services
Office of Technology Transfer
National Institutes of Health
6011 Executive Boulevard
Suite 325, MSC 7660
Bethesda, Maryland 20892-7660 / US
[2016/27]
Inventor(s)01 / FELGNER, Philip
c/o Antigen Discovery Inc.
1 Technology Dr. E309
Irvine, CA 92618 / US
02 / HOFFMAN, Stephen L.
c/o Sanaria Inc.
9800 Medical Center Dr. A209
Rockville, MD 20850 / US
03 / SEDER, Robert
c/o National Institutes of Health
Office of Technology Transfer
6011 Executive Boulevard
Suite 325, MSC 7660
Bethesda, Maryland 20892-7660 / US
 [2016/27]
Representative(s)Wibbelmann, Jobst
Wuesthoff & Wuesthoff
Patentanwälte und Rechtsanwalt PartG mbB
Schweigerstrasse 2
81541 München / DE
[N/P]
Former [2016/27]Wibbelmann, Jobst
Wuesthoff & Wuesthoff
Patentanwälte PartG mbB
Schweigerstrasse 2
81541 München / DE
Application number, filing date14839238.402.09.2014
[2016/27]
WO2014US53745
Priority number, dateUS201361872527P30.08.2013         Original published format: US 201361872527 P
[2016/27]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2015031904
Date:05.03.2015
Language:EN
[2015/09]
Type: A2 Application without search report 
No.:EP3039421
Date:06.07.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 05.03.2015 takes the place of the publication of the European patent application.
[2016/27]
Search report(s)International search report - published on:US23.04.2015
(Supplementary) European search report - dispatched on:EP08.03.2017
ClassificationIPC:A61K39/015, G01N33/68
[2017/14]
CPC:
G01N33/6854 (EP,US); A61K39/015 (EP,US); G01N2333/445 (EP,US);
G01N2469/20 (EP,US); Y02A50/30 (EP)
Former IPC [2016/27]G01N33/00, G01N33/569
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/27]
TitleGerman:SERUM-ANTIKÖRPER-ASSAY ZUR BESTIMMUNG DES SCHUTZES GEGEN MALARIA UND PRÄ-ERYTHROZYTÄRE SUBUNIT-IMPFSTOFF[2016/27]
English:SERUM ANTIBODY ASSAY FOR DETERMINING PROTECTION FROM MALARIA, AND PRE-ERYTHROCYTIC SUBUNIT VACCINES[2016/27]
French:DOSAGE D'ANTICORPS SÉRIQUES PERMETTANT DE DÉTERMINER LA PROTECTION CONTRE LE PALUDISME ET VACCINS SOUS-UNITAIRES DIRIGÉS CONTRE LES STADES PRÉ-ÉRYTHROCYTAIRES[2016/27]
Entry into regional phase21.03.2016National basic fee paid 
21.03.2016Search fee paid 
21.03.2016Designation fee(s) paid 
21.03.2016Examination fee paid 
Examination procedure21.03.2016Examination requested  [2016/27]
20.10.2016Amendment by applicant (claims and/or description)
05.10.2017Application deemed to be withdrawn, date of legal effect  [2018/14]
15.11.2017Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2018/14]
Fees paidRenewal fee
22.09.2016Renewal fee patent year 03
26.09.2017Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[YA]  - ANDREW M. REDMOND ET AL, "The Australasian Contribution to Malaria Vaccine Development", PARASITE IMMUNOLOGY., GB, (20100401), doi:10.1111/j.1365-3024.2010.01229.x, ISSN 0141-9838, pages no - no, XP055350162 [Y] 1,3-14 * abstract * * page 610, column 2, paragraphs 2-4 * * page 613, column 2, paragraph 3 * [A] 2,15

DOI:   http://dx.doi.org/10.1111/j.1365-3024.2010.01229.x
 [YA]  - UDAYVENKAT MATETI ET AL, "Advanced malarial vaccines: A promising approach in the treatment of malaria", SYSTEMATIC REVIEWS IN PHARMACY, IND, (20120101), vol. 3, no. 1, doi:10.4103/0975-8453.107136, ISSN 0975-8453, page 31, XP055350166 [Y] 1,3-14 * abstract * * page 32, column 1, paragraph 1 * * page 32, column 2, paragraph 2 * * table 1 * [A] 2,15

DOI:   http://dx.doi.org/10.4103/0975-8453.107136
International search[X]US2008260763  (FELGNER PHILIP [US], et al);
 [A]WO2006061965  (UNIV OSAKA [JP], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.